Insider Trades255 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | Sell | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 2,000 | $320.90 | $47.4B | -4.15% | +108.94% | $641.8K | -50.00% | — | Sell Now |
| Aug 3, 2026 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 295 | $267.99 | $47.4B | -4.15% | +108.94% | $79.1K | -0.16% | — | Sell Now |
| Aug 3, 2026 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 334 | $267.99 | $47.4B | -4.15% | +108.94% | $89.5K | -0.20% | — | Sell Now |
| Aug 3, 2026 | Sell | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 731 | $267.99 | $47.4B | -4.15% | +108.94% | $195.9K | -0.03% | — | Sell Now |
| Aug 3, 2026 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 795 | $271.74 | $47.4B | -4.15% | +108.94% | $216.0K | -0.76% | — | Sell Now |
| Aug 3, 2026 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 3,076 | $266.39 | $47.4B | -4.15% | +108.94% | $819.4K | -0.43% | — | Sell Now |
| Aug 3, 2026 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 3,410 | $265.58 | $47.4B | -4.15% | +108.94% | $905.6K | -0.37% | — | Sell Now |
| Jul 27, 2026 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 1,713 | $257.00 | $47.4B | -4.15% | +108.94% | $440.2K | -0.46% | — | Sell Now |
| Jul 27, 2026 | Sell | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 1,718 | $260.49 | $47.4B | -4.15% | +108.94% | $447.5K | -0.08% | — | Sell Now |
| Jul 27, 2026 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 1,887 | $257.08 | $47.4B | -4.15% | +108.94% | $485.1K | -0.55% | — | Sell Now |
| Jul 27, 2026 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 2,214 | $257.00 | $47.4B | -4.15% | +108.94% | $569.0K | -0.83% | — | Sell Now |
| Jul 27, 2026 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 5,064 | $253.28 | $47.4B | -4.15% | +108.94% | $1.3M | -1.82% | — | Sell Now |
| Jul 27, 2026 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 5,770 | $256.51 | $47.4B | -4.15% | +108.94% | $1.5M | -2.68% | — | Sell Now |
| Jul 6, 2026 | Sell | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 1,000 | $280.00 | $47.4B | -4.15% | +108.94% | $280.0K | -20.00% | — | Sell Now |
| Jul 1, 2026 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 3,000 | $272.90 | $47.4B | -4.15% | +108.94% | $818.7K | -0.73% | — | Sell Now |
| Jul 1, 2026 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 16,800 | $272.29 | $47.4B | -4.15% | +108.94% | $4.6M | -0.78% | — | Sell Now |
| Jun 24, 2026 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 33,600 | $251.65 | $47.4B | -4.15% | +108.94% | $8.5M | -4.03% | — | Sell Now |
| Jun 12, 2026 | Sell | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 100,000 | $214.47 | $47.4B | -4.15% | +108.94% | $21.4M | -0.20% | — | Sell Now |
| Jun 4, 2026 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 41,124 | $221.03 | $47.4B | -4.15% | +108.94% | $9.1M | -2.20% | — | Sell Now |
| Jun 1, 2026 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 3,000 | $218.43 | $47.4B | -4.15% | +108.94% | $655.3K | -0.54% | — | Sell Now |
| May 26, 2026 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 1,438 | $202.84 | $47.4B | -4.15% | +108.94% | $291.7K | -0.77% | — | Sell Now |
| May 26, 2026 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 1,652 | $202.84 | $47.4B | -4.15% | +108.94% | $335.1K | -1.16% | — | Sell Now |
| May 4, 2026 | Sell | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 7,708 | $213.05 | $47.4B | -4.15% | +108.94% | $1.6M | -0.06% | — | Sell Now |
| May 1, 2026 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 291 | $206.16 | $47.4B | -4.15% | +108.94% | $60.0K | -0.16% | — | Sell Now |
| May 1, 2026 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 330 | $206.16 | $47.4B | -4.15% | +108.94% | $68.0K | -0.15% | — | Sell Now |
| May 1, 2026 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 795 | $208.79 | $47.4B | -4.15% | +108.94% | $166.0K | -0.68% | — | Sell Now |
| May 1, 2026 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 902 | $206.16 | $47.4B | -4.15% | +108.94% | $186.0K | -0.60% | — | Sell Now |
| May 1, 2026 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 3,405 | $203.69 | $47.4B | -4.15% | +108.94% | $693.6K | -0.34% | — | Sell Now |
| Apr 27, 2026 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 1,688 | $204.10 | $47.4B | -4.15% | +108.94% | $344.5K | -0.45% | — | Sell Now |
| Apr 27, 2026 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 1,861 | $204.09 | $47.4B | -4.15% | +108.94% | $379.8K | -0.41% | — | Sell Now |
| Apr 27, 2026 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 2,182 | $204.10 | $47.4B | -4.15% | +108.94% | $445.3K | -0.74% | — | Sell Now |
| Apr 27, 2026 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 5,063 | $197.84 | $47.4B | -4.15% | +108.94% | $1.0M | -1.19% | — | Sell Now |
| Apr 27, 2026 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 5,838 | $204.14 | $47.4B | -4.15% | +108.94% | $1.2M | -1.88% | — | Sell Now |
| Apr 6, 2026 | Buy | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 85,902 | $72.36 | $47.4B | -4.15% | +108.94% | $6.2M | +0.64% | — | Sell Now |
| Apr 1, 2026 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 3,000 | $202.30 | $47.4B | -4.15% | +108.94% | $606.9K | -0.67% | — | Sell Now |
| Apr 1, 2026 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 8,400 | $203.31 | $47.4B | -4.15% | +108.94% | $1.7M | -0.73% | — | Sell Now |
| Mar 31, 2026 | Buy | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 41,708 | $9.59 | $47.4B | -4.15% | +108.94% | $400.0K | +1.76% | — | Sell Now |
| Mar 12, 2026 | Sell | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 400,000 | $100.50 | $47.4B | -4.15% | +108.94% | $40.2M | +0.00% | — | Sell Now |
| Mar 10, 2026 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 707 | $204.13 | $47.4B | -4.15% | +108.94% | $144.3K | -0.37% | — | Sell Now |
| Mar 10, 2026 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 785 | $204.13 | $47.4B | -4.15% | +108.94% | $160.2K | -1.22% | — | Sell Now |
| Mar 10, 2026 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 915 | $204.13 | $47.4B | -4.15% | +108.94% | $186.8K | -0.60% | — | Sell Now |
| Mar 10, 2026 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 1,745 | $204.13 | $47.4B | -4.15% | +108.94% | $356.2K | -0.74% | — | Sell Now |
| Mar 10, 2026 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 5,623 | $204.13 | $47.4B | -4.15% | +108.94% | $1.1M | -3.47% | — | Sell Now |
| Mar 6, 2026 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 13,996 | $125.53 | $47.4B | -4.15% | +108.94% | $1.8M | -0.20% | — | Sell Now |
| Mar 2, 2026 | Buy | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 8,125 | $79.84 | $47.4B | -4.15% | +108.94% | $648.7K | +0.35% | — | Sell Now |
| Mar 2, 2026 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 3,950 | $200.02 | $47.4B | -4.15% | +108.94% | $790.1K | -0.83% | — | Sell Now |
| Feb 3, 2026 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 1,334 | $230.77 | $47.4B | -4.15% | +108.94% | $307.8K | -0.59% | — | Sell Now |
| Feb 3, 2026 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 3,594 | $231.02 | $47.4B | -4.15% | +108.94% | $830.3K | -0.99% | — | Sell Now |
| Feb 3, 2026 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 6,939 | $227.83 | $47.4B | -4.15% | +108.94% | $1.6M | -3.99% | — | Sell Now |
| Feb 2, 2026 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 4,639 | $231.20 | $47.4B | -4.15% | +108.94% | $1.1M | -0.47% | — | Sell Now |
| Feb 2, 2026 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 90,024 | $230.72 | $47.4B | -4.15% | +108.94% | $20.8M | -8.04% | — | Sell Now |
| Jan 27, 2026 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 1,712 | $238.98 | $47.4B | -4.15% | +108.94% | $409.1K | -0.48% | — | Sell Now |
| Jan 27, 2026 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 1,886 | $239.01 | $47.4B | -4.15% | +108.94% | $450.8K | -0.42% | — | Sell Now |
| Jan 27, 2026 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 2,213 | $238.98 | $47.4B | -4.15% | +108.94% | $528.9K | -0.77% | — | Sell Now |
| Jan 27, 2026 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 5,064 | $235.38 | $47.4B | -4.15% | +108.94% | $1.2M | -1.63% | — | Sell Now |
| Jan 27, 2026 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 5,970 | $238.78 | $47.4B | -4.15% | +108.94% | $1.4M | -1.37% | — | Sell Now |
| Jan 20, 2026 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 18,145 | $234.74 | $47.4B | -4.15% | +108.94% | $4.3M | -4.86% | — | Sell Now |
| Jan 20, 2026 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 19,672 | $234.74 | $47.4B | -4.15% | +108.94% | $4.6M | -4.16% | — | Sell Now |
| Jan 20, 2026 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 23,498 | $234.74 | $47.4B | -4.15% | +108.94% | $5.5M | -7.50% | — | Sell Now |
| Jan 20, 2026 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 61,123 | $239.49 | $47.4B | -4.15% | +108.94% | $14.6M | -18.77% | — | Sell Now |
| Jan 20, 2026 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 73,522 | $234.74 | $47.4B | -4.15% | +108.94% | $17.3M | -14.42% | — | Sell Now |
| Jan 2, 2026 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 2,951 | $228.95 | $47.4B | -4.15% | +108.94% | $675.6K | -1.17% | — | Sell Now |
| Jan 2, 2026 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 3,848 | $229.08 | $47.4B | -4.15% | +108.94% | $881.5K | -1.38% | — | Sell Now |
| Dec 12, 2025 | Buy | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 27,363 | $47.41 | $47.4B | -4.15% | +108.94% | $1.3M | +3.00% | — | Sell Now |
| Dec 4, 2025 | Buy | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 6,902 | $19.68 | $47.4B | -4.15% | +108.94% | $135.8K | +3.33% | — | Sell Now |
| Dec 1, 2025 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 3,000 | $238.15 | $47.4B | -4.15% | +108.94% | $714.5K | -0.68% | — | Sell Now |
| Dec 1, 2025 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 4,400 | $238.07 | $47.4B | -4.15% | +108.94% | $1.0M | -1.02% | — | Sell Now |
| Nov 4, 2025 | Sell | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 22,900 | $200.51 | $47.4B | -4.15% | +108.94% | $4.6M | -0.50% | — | Sell Now |
| Nov 3, 2025 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 3,000 | $198.60 | $47.4B | -4.15% | +108.94% | $595.8K | -0.88% | — | Sell Now |
| Nov 3, 2025 | Sell | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 17,100 | $200.00 | $47.4B | -4.15% | +108.94% | $3.4M | -0.74% | — | Sell Now |
| Nov 3, 2025 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 316,382 | $158.66 | $47.4B | -4.15% | +108.94% | $50.2M | -0.37% | — | Sell Now |
| Oct 27, 2025 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 1,709 | $191.86 | $47.4B | -4.15% | +108.94% | $327.9K | -0.56% | — | Sell Now |
| Oct 27, 2025 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 1,993 | $191.87 | $47.4B | -4.15% | +108.94% | $382.4K | -0.49% | — | Sell Now |
| Oct 27, 2025 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 2,206 | $191.86 | $47.4B | -4.15% | +108.94% | $423.2K | -0.94% | — | Sell Now |
| Oct 27, 2025 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 5,063 | $191.15 | $47.4B | -4.15% | +108.94% | $967.8K | -0.85% | — | Sell Now |
| Oct 27, 2025 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 6,015 | $191.80 | $47.4B | -4.15% | +108.94% | $1.2M | -1.94% | — | Sell Now |
| Oct 22, 2025 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 2,170 | $190.30 | $47.4B | -4.15% | +108.94% | $413.0K | -1.03% | — | Sell Now |
| Oct 21, 2025 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 292 | $187.95 | $47.4B | -4.15% | +108.94% | $54.9K | -0.25% | — | Sell Now |
| Oct 21, 2025 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 339 | $187.95 | $47.4B | -4.15% | +108.94% | $63.7K | -0.22% | — | Sell Now |
| Oct 21, 2025 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 464 | $187.95 | $47.4B | -4.15% | +108.94% | $87.2K | -0.23% | — | Sell Now |
| Oct 21, 2025 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 602 | $187.95 | $47.4B | -4.15% | +108.94% | $113.1K | -0.83% | — | Sell Now |
| Oct 21, 2025 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 1,603 | $187.95 | $47.4B | -4.15% | +108.94% | $301.3K | -1.00% | — | Sell Now |
| Oct 20, 2025 | Sell | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 10,000 | $190.00 | $47.4B | -4.15% | +108.94% | $1.9M | -66.67% | — | Sell Now |
| Oct 1, 2025 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 3,000 | $159.99 | $47.4B | -4.15% | +108.94% | $480.0K | -0.84% | — | Sell Now |
| Sep 30, 2025 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 1,364 | $162.05 | $47.4B | -4.15% | +108.94% | $221.0K | -0.67% | — | Sell Now |
| Sep 30, 2025 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 2,491 | $162.05 | $47.4B | -4.15% | +108.94% | $403.7K | -3.48% | — | Sell Now |
| Sep 30, 2025 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 23,192 | $160.80 | $47.4B | -4.15% | +108.94% | $3.7M | -2.81% | — | Sell Now |
| Sep 18, 2025 | Sell | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 50,000 | $180.33 | $47.4B | -4.15% | +108.94% | $9.0M | -0.71% | — | Sell Now |
| Sep 15, 2025 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 300 | $172.16 | $47.4B | -4.15% | +108.94% | $51.6K | -0.25% | — | Sell Now |
| Sep 12, 2025 | Sell | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 5,000 | $170.54 | $47.4B | -4.15% | +108.94% | $852.7K | -9.01% | — | Sell Now |
| Sep 2, 2025 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 3,000 | $166.62 | $47.4B | -4.15% | +108.94% | $499.9K | -0.81% | — | Sell Now |
| Sep 2, 2025 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 5,079 | $166.53 | $47.4B | -4.15% | +108.94% | $845.8K | -1.05% | — | Sell Now |
| Aug 14, 2025 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 678 | $155.46 | $47.4B | -4.15% | +108.94% | $105.4K | -0.22% | — | Sell Now |
| Aug 14, 2025 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 875 | $155.46 | $47.4B | -4.15% | +108.94% | $136.0K | -0.35% | — | Sell Now |
| Aug 1, 2025 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 3,000 | $132.89 | $47.4B | -4.15% | +108.94% | $398.7K | -0.80% | — | Sell Now |
| Aug 1, 2025 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 5,807 | $132.88 | $47.4B | -4.15% | +108.94% | $771.7K | -1.73% | — | Sell Now |
| Jul 28, 2025 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 1,710 | $139.81 | $47.4B | -4.15% | +108.94% | $239.1K | -1.11% | — | Sell Now |
| Jul 28, 2025 | Sell | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 1,718 | $139.81 | $47.4B | -4.15% | +108.94% | $240.2K | -0.07% | — | Sell Now |
| Jul 28, 2025 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 1,994 | $139.81 | $47.4B | -4.15% | +108.94% | $278.8K | -0.98% | — | Sell Now |
| Jul 28, 2025 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 2,206 | $139.81 | $47.4B | -4.15% | +108.94% | $308.4K | -1.72% | — | Sell Now |
| Jul 28, 2025 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 5,064 | $138.36 | $47.4B | -4.15% | +108.94% | $700.7K | -1.85% | — | Sell Now |
| Jul 28, 2025 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 6,092 | $139.81 | $47.4B | -4.15% | +108.94% | $851.7K | -3.47% | — | Sell Now |
| Jul 22, 2025 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 2,170 | $139.94 | $47.4B | -4.15% | +108.94% | $303.7K | -0.76% | — | Sell Now |
| Jul 21, 2025 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 602 | $139.29 | $47.4B | -4.15% | +108.94% | $83.9K | -0.80% | — | Sell Now |
| Jul 21, 2025 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 1,622 | $139.29 | $47.4B | -4.15% | +108.94% | $225.9K | -0.88% | — | Sell Now |
| Jul 1, 2025 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 3,000 | $166.77 | $47.4B | -4.15% | +108.94% | $500.3K | -0.57% | — | Sell Now |
| Jul 1, 2025 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 5,343 | $166.53 | $47.4B | -4.15% | +108.94% | $889.8K | -0.75% | — | Sell Now |
| Jun 18, 2025 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 20,372 | $169.79 | $47.4B | -4.15% | +108.94% | $3.5M | -2.40% | — | Sell Now |
| Jun 2, 2025 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 3,000 | $157.07 | $47.4B | -4.15% | +108.94% | $471.2K | -0.56% | — | Sell Now |
| Jun 2, 2025 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 6,111 | $157.10 | $47.4B | -4.15% | +108.94% | $960.1K | -1.11% | — | Sell Now |
| May 27, 2025 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 1,777 | $153.50 | $47.4B | -4.15% | +108.94% | $272.8K | -0.58% | — | Sell Now |
| May 27, 2025 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 1,940 | $154.22 | $47.4B | -4.15% | +108.94% | $299.2K | -0.75% | — | Sell Now |
| May 15, 2025 | Sell | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 54,000 | $155.26 | $47.4B | -4.15% | +108.94% | $8.4M | -15.13% | — | Sell Now |
| May 1, 2025 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 3,000 | $150.12 | $47.4B | -4.15% | +108.94% | $450.4K | -0.54% | — | Sell Now |
| May 1, 2025 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 6,980 | $150.10 | $47.4B | -4.15% | +108.94% | $1.0M | -0.92% | — | Sell Now |
| Apr 28, 2025 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 1,709 | $152.18 | $47.4B | -4.15% | +108.94% | $260.1K | -1.09% | — | Sell Now |
| Apr 28, 2025 | Sell | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 1,718 | $152.18 | $47.4B | -4.15% | +108.94% | $261.4K | -0.07% | — | Sell Now |
| Apr 28, 2025 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 1,993 | $152.18 | $47.4B | -4.15% | +108.94% | $303.3K | -0.88% | — | Sell Now |
| Apr 28, 2025 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 2,281 | $147.18 | $47.4B | -4.15% | +108.94% | $335.7K | -0.81% | — | Sell Now |
| Apr 28, 2025 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 5,063 | $153.38 | $47.4B | -4.15% | +108.94% | $776.6K | -1.39% | — | Sell Now |
| Apr 28, 2025 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 6,203 | $152.18 | $47.4B | -4.15% | +108.94% | $944.0K | -3.13% | — | Sell Now |
| Apr 22, 2025 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 2,161 | $148.92 | $47.4B | -4.15% | +108.94% | $321.8K | -0.56% | — | Sell Now |
| Apr 21, 2025 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 296 | $145.56 | $47.4B | -4.15% | +108.94% | $43.1K | -0.10% | — | Sell Now |
| Apr 21, 2025 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 343 | $145.55 | $47.4B | -4.15% | +108.94% | $49.9K | -0.11% | — | Sell Now |
| Apr 21, 2025 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 470 | $145.55 | $47.4B | -4.15% | +108.94% | $68.4K | -0.10% | — | Sell Now |
| Apr 21, 2025 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 610 | $145.55 | $47.4B | -4.15% | +108.94% | $88.8K | -0.39% | — | Sell Now |
| Apr 21, 2025 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 1,664 | $145.55 | $47.4B | -4.15% | +108.94% | $242.2K | -0.41% | — | Sell Now |
| Apr 1, 2025 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 3,000 | $140.48 | $47.4B | -4.15% | +108.94% | $421.4K | -0.70% | — | Sell Now |
| Mar 31, 2025 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 1,404 | $138.41 | $47.4B | -4.15% | +108.94% | $194.3K | -0.31% | — | Sell Now |
| Mar 31, 2025 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 2,562 | $138.41 | $47.4B | -4.15% | +108.94% | $354.6K | -1.60% | — | Sell Now |
| Mar 31, 2025 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 25,461 | $139.70 | $47.4B | -4.15% | +108.94% | $3.6M | -2.00% | — | Sell Now |
| Mar 17, 2025 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 792 | $146.04 | $47.4B | -4.15% | +108.94% | $115.7K | -0.55% | — | Sell Now |
| Mar 17, 2025 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 795 | $146.04 | $47.4B | -4.15% | +108.94% | $116.1K | -0.25% | — | Sell Now |
| Mar 17, 2025 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 928 | $146.04 | $47.4B | -4.15% | +108.94% | $135.5K | -0.21% | — | Sell Now |
| Mar 17, 2025 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 1,026 | $146.04 | $47.4B | -4.15% | +108.94% | $149.8K | -0.35% | — | Sell Now |
| Mar 17, 2025 | Sell | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 1,127 | $146.04 | $47.4B | -4.15% | +108.94% | $164.6K | -0.02% | — | Sell Now |
| Mar 17, 2025 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 6,702 | $146.03 | $47.4B | -4.15% | +108.94% | $978.7K | -3.19% | — | Sell Now |
| Mar 14, 2025 | Sell | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 50,000 | $147.70 | $47.4B | -4.15% | +108.94% | $7.4M | -0.42% | — | Sell Now |
| Mar 5, 2025 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 6,000 | $143.29 | $47.4B | -4.15% | +108.94% | $859.7K | -1.02% | — | Sell Now |
| Mar 5, 2025 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 87,272 | $143.40 | $47.4B | -4.15% | +108.94% | $12.5M | -7.06% | — | Sell Now |
| Feb 6, 2025 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 663 | $177.77 | $47.4B | -4.15% | +108.94% | $117.9K | -0.42% | — | Sell Now |
| Feb 6, 2025 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 1,632 | $177.77 | $47.4B | -4.15% | +108.94% | $290.1K | -1.08% | — | Sell Now |
| Jan 31, 2025 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 43,902 | $176.85 | $47.4B | -4.15% | +108.94% | $7.8M | -8.69% | — | Sell Now |
| Jan 29, 2025 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 4,030 | $165.87 | $47.4B | -4.15% | +108.94% | $668.5K | -0.92% | — | Sell Now |
| Jan 29, 2025 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 4,773 | $165.87 | $47.4B | -4.15% | +108.94% | $791.7K | -0.74% | — | Sell Now |
| Jan 29, 2025 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 5,201 | $165.87 | $47.4B | -4.15% | +108.94% | $862.7K | -1.25% | — | Sell Now |
| Jan 29, 2025 | Sell | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 6,003 | $165.87 | $47.4B | -4.15% | +108.94% | $995.7K | -0.13% | — | Sell Now |
| Jan 29, 2025 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 6,221 | $169.12 | $47.4B | -4.15% | +108.94% | $1.1M | -1.18% | — | Sell Now |
| Jan 29, 2025 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 13,685 | $165.87 | $47.4B | -4.15% | +108.94% | $2.3M | -1.30% | — | Sell Now |
| Jan 27, 2025 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 1,442 | $161.87 | $47.4B | -4.15% | +108.94% | $233.4K | -1.32% | — | Sell Now |
| Jan 23, 2025 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 1,441 | $171.67 | $47.4B | -4.15% | +108.94% | $247.4K | -0.43% | — | Sell Now |
| Jan 22, 2025 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 21,228 | $164.97 | $47.4B | -4.15% | +108.94% | $3.5M | -6.72% | — | Sell Now |
| Jan 22, 2025 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 22,039 | $164.97 | $47.4B | -4.15% | +108.94% | $3.6M | -4.78% | — | Sell Now |
| Jan 22, 2025 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 24,861 | $164.97 | $47.4B | -4.15% | +108.94% | $4.1M | -8.12% | — | Sell Now |
| Jan 22, 2025 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 25,931 | $164.97 | $47.4B | -4.15% | +108.94% | $4.3M | -10.31% | — | Sell Now |
| Jan 22, 2025 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 78,553 | $164.97 | $47.4B | -4.15% | +108.94% | $13.0M | -12.52% | — | Sell Now |
| Jan 8, 2025 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 6,223 | $175.30 | $47.4B | -4.15% | +108.94% | $1.1M | -3.02% | — | Sell Now |
| Dec 23, 2024 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 669 | $159.60 | $47.4B | -4.15% | +108.94% | $106.8K | -0.29% | — | Sell Now |
| Dec 23, 2024 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 2,428 | $159.60 | $47.4B | -4.15% | +108.94% | $387.5K | -0.68% | — | Sell Now |
| Dec 19, 2024 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 206 | $158.09 | $47.4B | -4.15% | +108.94% | $32.6K | -0.09% | — | Sell Now |
| Dec 13, 2024 | Sell | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 160,000 | $165.74 | $47.4B | -4.15% | +108.94% | $26.5M | -1.30% | — | Sell Now |
| Dec 9, 2024 | Buy | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 13,933 | $64.23 | $47.4B | -4.15% | +108.94% | $894.9K | +1.22% | — | Sell Now |
| Dec 5, 2024 | Buy | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 68,496 | $5.40 | $47.4B | -4.15% | +108.94% | $369.6K | +2.76% | — | Sell Now |
| Nov 25, 2024 | Sell | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 4,000 | $166.34 | $47.4B | -4.15% | +108.94% | $665.4K | -0.77% | — | Sell Now |
| Nov 15, 2024 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 4,728 | $146.41 | $47.4B | -4.15% | +108.94% | $692.2K | -0.42% | — | Sell Now |
| Nov 11, 2024 | Buy | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 140,000 | $5.40 | $47.4B | -4.15% | +108.94% | $755.3K | +2.82% | — | Sell Now |
| Oct 31, 2024 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 1,866 | $126.45 | $47.4B | -4.15% | +108.94% | $236.0K | -2.64% | — | Sell Now |
| Oct 28, 2024 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 929 | $118.21 | $47.4B | -4.15% | +108.94% | $109.8K | -0.81% | — | Sell Now |
| Oct 28, 2024 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 1,057 | $118.21 | $47.4B | -4.15% | +108.94% | $124.9K | -0.51% | — | Sell Now |
| Oct 28, 2024 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 1,196 | $118.21 | $47.4B | -4.15% | +108.94% | $141.4K | -1.07% | — | Sell Now |
| Oct 28, 2024 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 1,992 | $118.86 | $47.4B | -4.15% | +108.94% | $236.8K | -1.38% | — | Sell Now |
| Oct 28, 2024 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 3,960 | $118.21 | $47.4B | -4.15% | +108.94% | $468.1K | -2.04% | — | Sell Now |
| Oct 24, 2024 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 1,605 | $119.03 | $47.4B | -4.15% | +108.94% | $191.0K | -1.09% | — | Sell Now |
| Oct 23, 2024 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 496 | $119.09 | $47.4B | -4.15% | +108.94% | $59.1K | -0.62% | — | Sell Now |
| Oct 21, 2024 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 541 | $120.50 | $47.4B | -4.15% | +108.94% | $65.2K | -0.24% | — | Sell Now |
| Oct 21, 2024 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 550 | $120.44 | $47.4B | -4.15% | +108.94% | $66.2K | -0.24% | — | Sell Now |
| Oct 21, 2024 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 816 | $120.46 | $47.4B | -4.15% | +108.94% | $98.3K | -0.19% | — | Sell Now |
| Oct 21, 2024 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 1,062 | $120.46 | $47.4B | -4.15% | +108.94% | $127.9K | -0.67% | — | Sell Now |
| Oct 21, 2024 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 2,602 | $120.52 | $47.4B | -4.15% | +108.94% | $313.6K | -0.64% | — | Sell Now |
| Oct 15, 2024 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 4,523 | $130.40 | $47.4B | -4.15% | +108.94% | $589.8K | -2.31% | — | Sell Now |
| Sep 16, 2024 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 5,024 | $128.48 | $47.4B | -4.15% | +108.94% | $645.5K | -0.51% | — | Sell Now |
| Aug 15, 2024 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 5,583 | $118.91 | $47.4B | -4.15% | +108.94% | $663.9K | -1.37% | — | Sell Now |
| Aug 13, 2024 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 3,956 | $116.67 | $47.4B | -4.15% | +108.94% | $461.5K | -3.34% | — | Sell Now |
| Aug 8, 2024 | Buy | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 190,000 | $5.40 | $47.4B | -4.15% | +108.94% | $1.0M | +12.67% | — | Sell Now |
| Jul 29, 2024 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 1,029 | $93.30 | $47.4B | -4.15% | +108.94% | $96.0K | -0.38% | — | Sell Now |
| Jul 29, 2024 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 1,057 | $102.77 | $47.4B | -4.15% | +108.94% | $108.6K | -0.51% | — | Sell Now |
| Jul 29, 2024 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 1,196 | $102.77 | $47.4B | -4.15% | +108.94% | $122.9K | -1.05% | — | Sell Now |
| Jul 29, 2024 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 3,104 | $100.89 | $47.4B | -4.15% | +108.94% | $313.2K | -2.08% | — | Sell Now |
| Jul 29, 2024 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 4,084 | $102.77 | $47.4B | -4.15% | +108.94% | $419.7K | -1.94% | — | Sell Now |
| Jul 24, 2024 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 2,359 | $104.39 | $47.4B | -4.15% | +108.94% | $246.3K | -1.03% | — | Sell Now |
| Jul 22, 2024 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 549 | $105.16 | $47.4B | -4.15% | +108.94% | $57.7K | -0.50% | — | Sell Now |
| Jul 22, 2024 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 549 | $105.16 | $47.4B | -4.15% | +108.94% | $57.7K | -0.48% | — | Sell Now |
| Jul 22, 2024 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 815 | $105.16 | $47.4B | -4.15% | +108.94% | $85.7K | -0.38% | — | Sell Now |
| Jul 22, 2024 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 1,558 | $105.88 | $47.4B | -4.15% | +108.94% | $165.0K | -0.89% | — | Sell Now |
| Jul 22, 2024 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 2,638 | $105.16 | $47.4B | -4.15% | +108.94% | $277.4K | -1.11% | — | Sell Now |
| Jul 15, 2024 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 5,496 | $111.66 | $47.4B | -4.15% | +108.94% | $613.7K | -1.30% | — | Sell Now |
| Jul 1, 2024 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 2,723 | $108.37 | $47.4B | -4.15% | +108.94% | $295.1K | -1.27% | — | Sell Now |
| Jul 1, 2024 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 4,983 | $108.37 | $47.4B | -4.15% | +108.94% | $540.0K | -5.38% | — | Sell Now |
| Jul 1, 2024 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 37,500 | $108.10 | $47.4B | -4.15% | +108.94% | $4.1M | -5.13% | — | Sell Now |
| Jun 17, 2024 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 6,105 | $111.61 | $47.4B | -4.15% | +108.94% | $681.4K | -0.94% | — | Sell Now |
| May 28, 2024 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 1,438 | $109.96 | $47.4B | -4.15% | +108.94% | $158.1K | -1.29% | — | Sell Now |
| May 28, 2024 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 1,647 | $109.96 | $47.4B | -4.15% | +108.94% | $181.1K | -1.42% | — | Sell Now |
| May 15, 2024 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 6,779 | $107.08 | $47.4B | -4.15% | +108.94% | $725.9K | -1.51% | — | Sell Now |
| May 10, 2024 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 60,000 | $62.13 | $47.4B | -4.15% | +108.94% | $3.7M | +0.00% | — | Sell Now |
| May 8, 2024 | Buy | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 215,000 | $5.40 | $47.4B | -4.15% | +108.94% | $1.2M | +14.58% | — | Sell Now |
| May 1, 2024 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 1,866 | $93.97 | $47.4B | -4.15% | +108.94% | $175.3K | -0.68% | — | Sell Now |
| Apr 29, 2024 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 929 | $93.14 | $47.4B | -4.15% | +108.94% | $86.5K | -0.83% | — | Sell Now |
| Apr 29, 2024 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 1,057 | $93.14 | $47.4B | -4.15% | +108.94% | $98.4K | -0.51% | — | Sell Now |
| Apr 29, 2024 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 1,196 | $93.14 | $47.4B | -4.15% | +108.94% | $111.4K | -1.02% | — | Sell Now |
| Apr 29, 2024 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 1,238 | $93.14 | $47.4B | -4.15% | +108.94% | $115.3K | -1.75% | — | Sell Now |
| Apr 29, 2024 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 4,084 | $93.14 | $47.4B | -4.15% | +108.94% | $380.4K | -1.77% | — | Sell Now |
| Apr 24, 2024 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 2,393 | $91.67 | $47.4B | -4.15% | +108.94% | $219.4K | -1.11% | — | Sell Now |
| Apr 23, 2024 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 522 | $91.38 | $47.4B | -4.15% | +108.94% | $47.7K | -0.47% | — | Sell Now |
| Apr 23, 2024 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 531 | $91.38 | $47.4B | -4.15% | +108.94% | $48.5K | -0.45% | — | Sell Now |
| Apr 23, 2024 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 787 | $91.38 | $47.4B | -4.15% | +108.94% | $71.9K | -0.37% | — | Sell Now |
| Apr 23, 2024 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 1,523 | $91.38 | $47.4B | -4.15% | +108.94% | $139.2K | -1.58% | — | Sell Now |
| Apr 23, 2024 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 2,552 | $91.38 | $47.4B | -4.15% | +108.94% | $233.2K | -0.97% | — | Sell Now |
| Apr 16, 2024 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 80,000 | $90.82 | $47.4B | -4.15% | +108.94% | $7.3M | -21.70% | — | Sell Now |
| Apr 15, 2024 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 6,816 | $93.13 | $47.4B | -4.15% | +108.94% | $634.8K | -0.98% | — | Sell Now |
| Apr 2, 2024 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 1,378 | $92.62 | $47.4B | -4.15% | +108.94% | $127.6K | -1.91% | — | Sell Now |
| Mar 28, 2024 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 464 | $90.42 | $47.4B | -4.15% | +108.94% | $42.0K | -0.41% | — | Sell Now |
| Mar 28, 2024 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 707 | $90.42 | $47.4B | -4.15% | +108.94% | $63.9K | -0.36% | — | Sell Now |
| Mar 28, 2024 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 743 | $90.42 | $47.4B | -4.15% | +108.94% | $67.2K | -0.36% | — | Sell Now |
| Mar 28, 2024 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 914 | $90.42 | $47.4B | -4.15% | +108.94% | $82.6K | -1.25% | — | Sell Now |
| Mar 15, 2024 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 53,572 | $89.09 | $47.4B | -4.15% | +108.94% | $4.8M | -15.36% | — | Sell Now |
| Mar 15, 2024 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 151,493 | $57.60 | $47.4B | -4.15% | +108.94% | $8.7M | -0.89% | — | Sell Now |
| Mar 5, 2024 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 1,838 | $88.36 | $47.4B | -4.15% | +108.94% | $162.4K | -0.80% | — | Sell Now |
| Mar 5, 2024 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 2,160 | $88.36 | $47.4B | -4.15% | +108.94% | $190.9K | -1.05% | — | Sell Now |
| Mar 5, 2024 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 2,245 | $88.36 | $47.4B | -4.15% | +108.94% | $198.4K | -0.56% | — | Sell Now |
| Mar 5, 2024 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 2,826 | $88.36 | $47.4B | -4.15% | +108.94% | $249.7K | -3.85% | — | Sell Now |
| Mar 5, 2024 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 9,326 | $88.36 | $47.4B | -4.15% | +108.94% | $824.1K | -3.64% | — | Sell Now |
| Mar 5, 2024 | Sell | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 191,012 | $87.40 | $47.4B | -4.15% | +108.94% | $16.7M | -3.22% | — | Sell Now |
| Feb 27, 2024 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 111,666 | $45.02 | $47.4B | -4.15% | +108.94% | $5.0M | +0.00% | — | Sell Now |
| Feb 23, 2024 | Buy | NTRA | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 380,036 | $2.66 | $47.4B | -4.15% | +108.94% | $1.0M | +56.72% | — | Sell Now |
| Feb 6, 2024 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 68,058 | $43.32 | $47.4B | -4.15% | +108.94% | $2.9M | +0.00% | — | Sell Now |
| Feb 1, 2024 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 22,281 | $67.73 | $47.4B | -4.15% | +108.94% | $1.5M | -23.98% | — | Sell Now |
| Jan 29, 2024 | Sell | NTRA | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | 2,358 | $65.09 | $47.4B | -4.15% | +108.94% | $153.5K | -2.13% | — | Sell Now |
| Jan 29, 2024 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 3,235 | $65.09 | $47.4B | -4.15% | +108.94% | $210.6K | -3.36% | — | Sell Now |
| Jan 29, 2024 | Sell | NTRA | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | 3,426 | $65.09 | $47.4B | -4.15% | +108.94% | $223.0K | -1.73% | — | Sell Now |
| Jan 29, 2024 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 4,265 | $65.09 | $47.4B | -4.15% | +108.94% | $277.6K | -2.05% | — | Sell Now |
| Jan 29, 2024 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 14,813 | $65.09 | $47.4B | -4.15% | +108.94% | $964.2K | -5.66% | — | Sell Now |
| Jan 24, 2024 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 944 | $67.00 | $47.4B | -4.15% | +108.94% | $63.2K | -1.44% | — | Sell Now |
| Jan 22, 2024 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 892 | $68.16 | $47.4B | -4.15% | +108.94% | $60.8K | -0.47% | — | Sell Now |
| Jan 22, 2024 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 1,958 | $68.16 | $47.4B | -4.15% | +108.94% | $133.5K | -0.92% | — | Sell Now |
| Jan 22, 2024 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 2,973 | $66.45 | $47.4B | -4.15% | +108.94% | $197.6K | -1.29% | — | Sell Now |
| Dec 28, 2023 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 728 | $63.29 | $47.4B | -4.15% | +108.94% | $46.1K | -0.40% | — | Sell Now |
| Dec 28, 2023 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 2,292 | $62.69 | $47.4B | -4.15% | +108.94% | $143.7K | -1.69% | — | Sell Now |
| Dec 28, 2023 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 2,604 | $63.29 | $47.4B | -4.15% | +108.94% | $164.8K | -1.45% | — | Sell Now |
| Nov 20, 2023 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 2,566 | $55.00 | $47.4B | -4.15% | +108.94% | $141.1K | -1.17% | — | Sell Now |
| Oct 23, 2023 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 803 | $40.39 | $47.4B | -4.15% | +108.94% | $32.4K | -0.42% | — | Sell Now |
| Oct 23, 2023 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 2,595 | $40.39 | $47.4B | -4.15% | +108.94% | $104.8K | -0.99% | — | Sell Now |
| Oct 23, 2023 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 3,940 | $40.40 | $47.4B | -4.15% | +108.94% | $159.2K | -1.71% | — | Sell Now |
| Sep 28, 2023 | Sell | NTRA | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | 732 | $45.82 | $47.4B | -4.15% | +108.94% | $33.5K | -0.40% | — | Sell Now |
| Sep 28, 2023 | Sell | NTRA | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 2,291 | $45.91 | $47.4B | -4.15% | +108.94% | $105.2K | -1.66% | — | Sell Now |
| Sep 28, 2023 | Sell | NTRA | Steven Leonard Chapman | CEO AND PRESIDENT | 2,617 | $45.82 | $47.4B | -4.15% | +108.94% | $119.9K | -1.14% | — | Sell Now |